Oncogenic role of DDX3 in breast cancer biogenesis

被引:179
|
作者
Botlagunta, M. [1 ]
Vesuna, F. [1 ]
Mironchik, Y. [1 ]
Raman, A. [2 ]
Lisok, A. [1 ]
Winnard, P., Jr. [1 ]
Mukadam, S. [1 ]
Van Diest, P. [3 ]
Chen, J. H. [4 ]
Farabaugh, P.
Patel, A. H. [5 ]
Raman, V. [6 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA
[2] Univ Maryland, Dept Biol, Baltimore, MD 21201 USA
[3] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[4] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan
[5] Arvind Patel Inst Virol, Glasgow G11, Lanark, Scotland
[6] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
基金
英国医学研究理事会;
关键词
DDX3; breast cancer; BPDE;
D O I
10.1038/onc.2008.33
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Benzo[a] pyrene diol epoxide (BPDE), the active metabolite of benzo[a] pyrene present in tobacco smoke, is a major cancer-causing compound. To evaluate the effects of BPDE on human breast epithelial cells, we exposed an immortalized human breast cell line, MCF 10A, to BPDE and characterized the gene expression pattern. Of the differential genes expressed, we found consistent activation of DDX3, a member of the DEAD box RNA helicase family. Overexpression of DDX3 in MCF 10A cells induced an epithelial-mesenchymal- like transformation, exhibited increased motility and invasive properties, and formed colonies in soft-agar assays. Besides the altered phenotype, MCF 10A-DDX3 cells repressed E-cadherin expression as demonstrated by both immunoblots and by E-cadherin promoter-reporter assays. In addition, an in vivo association of DDX3 and the E-cadherin promoter was demonstrated by chromatin immunoprecipitation assays. Collectively, these results demonstrate that the activation of DDX3 by BPDE, can promote growth, proliferation and neoplastic transformation of breast epithelial cells.
引用
收藏
页码:3912 / 3922
页数:11
相关论文
共 50 条
  • [1] Oncogenic role of DDX3 in breast cancer biogenesis
    M Botlagunta
    F Vesuna
    Y Mironchik
    A Raman
    A Lisok
    P Winnard
    S Mukadam
    P Van Diest
    J H Chen
    P Farabaugh
    A H Patel
    V Raman
    Oncogene, 2008, 27 : 3912 - 3922
  • [2] Cytoplasmic DDX3 as prognosticator in male breast cancer
    van der Pol, Carmen C.
    Moelans, Cathy B.
    Manson, Quirine F.
    Batenburg, Marilot C. T.
    van der Wall, Elsken
    Rinkes, Inne Borel
    Verkooijen, Lenny
    Raman, Venu
    van Diest, Paul J.
    VIRCHOWS ARCHIV, 2021, 479 (04) : 647 - 655
  • [3] Cytoplasmic DDX3 as prognosticator in male breast cancer
    Carmen C. van der Pol
    Cathy B. Moelans
    Quirine F. Manson
    Marilot C. T. Batenburg
    Elsken van der Wall
    Inne Borel Rinkes
    Lenny Verkooijen
    Venu Raman
    Paul J. van Diest
    Virchows Archiv, 2021, 479 : 647 - 655
  • [4] The role of DDX3 in regulating Snail
    Sun, Mianen
    Song, Ling
    Zhou, Tong
    Gillespie, G. Yancey
    Jope, Richard S.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2011, 1813 (03): : 438 - 447
  • [5] Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer
    Bol, Guus M.
    Raman, Venu
    van der Groep, Petra
    Vermeulen, Jeroen F.
    Patel, Arvind H.
    van der Wall, Elsken
    van Diest, Paul J.
    PLOS ONE, 2013, 8 (05):
  • [6] The prognostic effect of DDX3 upregulation in distant breast cancer metastases
    van Voss, Marise R. Heerma
    Schrijver, Willemijne A. M. E.
    ter Hoeve, Natalie D.
    Hoefnagel, Laurien D.
    Manson, Quirine F.
    van der Wall, Elsken
    Raman, Venu
    van Diest, Paul J.
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (01) : 85 - 92
  • [7] The prognostic effect of DDX3 upregulation in distant breast cancer metastases
    Marise R. Heerma van Voss
    Willemijne A. M. E. Schrijver
    Natalie D. ter Hoeve
    Laurien D. Hoefnagel
    Quirine F. Manson
    Elsken van der Wall
    Venu Raman
    Paul J. van Diest
    Clinical & Experimental Metastasis, 2017, 34 : 85 - 92
  • [8] DDX3, a potential target for cancer treatment
    Guus Martinus Bol
    Min Xie
    Venu Raman
    Molecular Cancer, 14
  • [9] DDX3, a potential target for cancer treatment
    Bol, Guus Martinus
    Xie, Min
    Raman, Venu
    MOLECULAR CANCER, 2015, 14
  • [10] Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
    van Voss, Marise R. Heerma
    Vesuna, Farhad
    Bol, Guus M.
    Meeldijk, Jan
    Raman, Ana
    Offerhaus, G. Johan
    Buerger, Horst
    Patel, Arvind H.
    van der Wall, Elsken
    van Diest, Paul J.
    Raman, Venu
    ONCOTARGETS AND THERAPY, 2017, 10 : 3501 - 3513